Moderna has reached an agreement with Singapore's Ministry of Health to supply its Covid-19 vaccine to the country, according to a news release from the drugmaker on Tuesday.
The company will supply approximately 500 million to “possibly up to 1 billion doses” of its Covid-19 vaccine starting 2021, the release said.
It added that Moderna is scaling up global manufacturing to be able to deliver on the agreement.
No financial details were made available in the release.
The agreement will "support ongoing efforts to secure access to a safe and effective Covid-19 vaccine for the people of Singapore," the biotechnology company said.
“We appreciate the confidence the Ministry of Health of Singapore has demonstrated in our mRNA vaccine platform by including mRNA-1273 in their portfolio of vaccines,” said Moderna CEO Stéphane Bancel.
Singapore also approved the Pfizer-BioNTech vaccine on Monday, with the first shipment due to arrive in the country by the end of this year.